Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China
· Delayed Price · Currency is CNY 3.570
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST
Shenzhen Glory Medical Revenue
Shenzhen Glory Medical had revenue of 257.39M CNY in the quarter ending March 31, 2026, a decrease of -7.99%. This brings the company's revenue in the last twelve months to 1.05B, down -27.34% year-over-year. In the year 2025, Shenzhen Glory Medical had annual revenue of 1.08B, down -25.61%.
Revenue (ttm)
1.05B
Revenue Growth
-27.34%
P/S Ratio
2.86
Revenue / Employee
748.19K
Employees
1,410
Market Cap
3.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.08B | -370.90M | -25.61% |
| Dec 31, 2024 | 1.45B | 255.32M | 21.40% |
| Dec 31, 2023 | 1.19B | -82.82M | -6.49% |
| Jan 1, 2023 | 1.28B | -514.59M | -28.74% |
| Jan 1, 2022 | 1.79B | -477.00M | -21.04% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Jan 1, 2020 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Realcan Pharmaceutical Group | 7.25B |
| Guangxi LiuYao Group | 20.95B |
| C.Q. Pharmaceutical Holding | 82.27B |
| China National Accord Medicines Corporation | 72.95B |
| Qingdao Baheal Medical INC. | 7.58B |
| China Meheco Group | 35.36B |
| Liaoning Cheng Da | 9.90B |
| China National Medicines Corporation | 53.31B |